Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2013
MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis
Catalina Perdomo, Joshua D Campbell, Joseph Gerrein, et al.
Leukemia
|
April 15, 2020
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Bone Marrow Transplantation
|
January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT
Stavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.
Bone Marrow Transplantation
|
April 1, 2022
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Hemasphere
|
March 9, 2023
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
Marie Robin, Liesbeth C de Wreede, Thomas Schroeder, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Leukemia
|
May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Haematologica
|
March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Laurent Garderet, Luuk Gras, Linda Koster, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
October 26, 2013
MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis
Catalina Perdomo, Joshua D Campbell, Joseph Gerrein, et al.
Leukemia
|
April 15, 2020
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernández-Boluda, Arturo Pereira, Nicolaus Kröger, et al.
Bone Marrow Transplantation
|
January 23, 2022
Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Bone Marrow Transplantation
|
October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT
Stavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.
Bone Marrow Transplantation
|
April 1, 2022
Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT
Juan-Carlos Hernández-Boluda, Arturo Pereira, Nienke Zinger, et al.
Hemasphere
|
March 9, 2023
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
Marie Robin, Liesbeth C de Wreede, Thomas Schroeder, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Leukemia
|
May 23, 2021
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
Nicolaus Kröger, Giulia Sbianchi, Tiarlan Sirait, et al.
Haematologica
|
March 28, 2024
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Laurent Garderet, Luuk Gras, Linda Koster, et al.
Page
of 8